These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35218698)

  • 1. Primary cell-free DNA screening or contingent screening for the common trisomies: a response.
    Dar P; Norton ME
    Am J Obstet Gynecol; 2022 Jul; 227(1):127-128. PubMed ID: 35218698
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating Cell-free DNA and Screening for Trisomies.
    Norton ME
    N Engl J Med; 2022 Oct; 387(14):1322-1324. PubMed ID: 36170494
    [No Abstract]   [Full Text] [Related]  

  • 3. Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.
    Galeva S; Konstantinidou L; Gil MM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Feb; 53(2):208-213. PubMed ID: 30353581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical application of a contingent screening strategy for trisomies with cell-free DNA: a pilot study.
    Sánchez-Durán MÁ; Bernabeu García A; Calero I; Ramis Fossas J; Illescas T; Avilés MT; Maiz N; Carreras E
    BMC Pregnancy Childbirth; 2019 Aug; 19(1):274. PubMed ID: 31370808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-free DNA analysis for noninvasive examination of trisomy: comparing 2 targeted methods.
    Conotte S; El Kenz H; De Marchin J; Jani JC
    Am J Obstet Gynecol; 2022 Sep; 227(3):539-541. PubMed ID: 35577013
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
    Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing.
    Nicolaides KH; Syngelaki A; Poon LC; Gil MM; Wright D
    Fetal Diagn Ther; 2014; 35(3):185-92. PubMed ID: 24192489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.
    Gil MM; Revello R; Poon LC; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):45-52. PubMed ID: 26498918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
    Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IONA test for first-trimester detection of trisomies 21, 18 and 13.
    Poon LC; Dumidrascu-Diris D; Francisco C; Fantasia I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):184-7. PubMed ID: 26387684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.
    Khalil A; Archer R; Hutchinson V; Mousa HA; Johnstone ED; Cameron MJ; Cohen KE; Ioannou C; Kelly B; Reed K; Hulme R; Papageorghiou AT
    Am J Obstet Gynecol; 2021 Jul; 225(1):79.e1-79.e13. PubMed ID: 33460583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-free DNA screening for trisomies 21, 18, and 13 in pregnancies at low and high risk for aneuploidy with genetic confirmation.
    Dar P; Jacobsson B; MacPherson C; Egbert M; Malone F; Wapner RJ; Roman AS; Khalil A; Faro R; Madankumar R; Edwards L; Haeri S; Silver R; Vohra N; Hyett J; Clunie G; Demko Z; Martin K; Rabinowitz M; Flood K; Carlsson Y; Doulaveris G; Malone C; Hallingstrom M; Klugman S; Clifton R; Kao C; Hakonarson H; Norton ME
    Am J Obstet Gynecol; 2022 Aug; 227(2):259.e1-259.e14. PubMed ID: 35085538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of the IONA test: a non-invasive prenatal screening test for trisomies 21, 18 and 13.
    Papageorghiou AT; Khalil A; Forman M; Hulme R; Mazey R; Mousa HA; Johnstone ED; McKelvey A; Cohen KE; Risley M; Denman W; Kelly B
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):188-93. PubMed ID: 26493543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MODELS OF CLINICAL IMPLEMENTATION OF CELL FREE FETAL DNA IN THE MATERNAL SERUM SCREENING TEST-ANALYSIS].
    Yankova M; Chaveeva P; Stratieva V
    Akush Ginekol (Sofiia); 2015; 54(7):15-21. PubMed ID: 27025103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contingent cfDNA Screening Implementation: Increasing Diagnostic Accuracy and Reducing Invasive Testing - 6 Years' Results in a Single Center.
    Cubo AM; Huélamo M; Martín-Seisdedos MC; Hernández-Hernández E; Lapresa-Alcalde MV; Rodríguez-Martín MO; Doyague MJ; Sayagués JM
    Fetal Diagn Ther; 2022; 49(3):103-113. PubMed ID: 35259749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practice.
    Salomon LJ; Alfirevic Z; Audibert F; Kagan KO; Paladini D; Yeo G; Raine-Fenning N;
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):815-816. PubMed ID: 28573775
    [No Abstract]   [Full Text] [Related]  

  • 18. [Analysis of follow-up information and pregnancy outcomes of cell free DNA prenatal screening].
    Liang D; Lin Y; Li H; Hu P; Xu ZF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Feb; 55(2):106-111. PubMed ID: 32146739
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.
    Gil MM; Quezada MS; Revello R; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Mar; 45(3):249-66. PubMed ID: 25639627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal reflex DNA screening for trisomies 21, 18, and 13.
    Wald NJ; Huttly WJ; Bestwick JP; Old R; Morris JK; Cheng R; Aquilina J; Peregrine E; Roberts D; Alfirevic Z
    Genet Med; 2018 Aug; 20(8):825-830. PubMed ID: 29120460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.